DR. JAMES STOWERS HICKS, M.D.
Anesthesiologist Assistant at Sam Jackson Park Rd, Portland, OR
License number
Oregon MD11564
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-4910
(503) 494-8368 (Fax)
(503) 494-8368 (Fax)
Personal information
See more information about JAMES STOWERS HICKS at radaris.comName
Address
Phone
496 SW 257Th Ave, Troutdale, OR 97060
5166 SE Naef Rd, Portland, OR 97267
Professional information
Independent Health, Wellness And Fitness Professional
Position:
Board Member at Project Access Now, Clinical Professor at Oregon Health & Science University
Location:
Portland, Oregon Area
Industry:
Health, Wellness and Fitness
Work:
Project Access Now
since 2005
-
Board Member
Oregon Health & Science University
since 1999
-
Clinical Professor
American Society of Anesthesiologists
1970 - 2011
-
Member
James Hicks - Portland, OR
Work:
MENDENHALL RIVER COMMUNITY SCHOOL
Principal GRANT COMMUNITY SCHOOL
Principal RICHMOND ELEMENTARY SCHOOL
Principal KEIZER ELEMENTARY SCHOOL
Assistant Principal PRATUM ELEMENTARY SCHOOL
Primary Teacher, Middle School PE and Health CALVARY CHRISTIAN SCHOOL
Kindergarten Teacher, Director, Substitute Teacher MAIN ELEMENTARY
Kindergarten Teacher
Principal GRANT COMMUNITY SCHOOL
Principal RICHMOND ELEMENTARY SCHOOL
Principal KEIZER ELEMENTARY SCHOOL
Assistant Principal PRATUM ELEMENTARY SCHOOL
Primary Teacher, Middle School PE and Health CALVARY CHRISTIAN SCHOOL
Kindergarten Teacher, Director, Substitute Teacher MAIN ELEMENTARY
Kindergarten Teacher
Dr. James S Hicks, Portland OR - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone), (503) 494-4997 (Fax)
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone), (503) 494-3092 (Fax)
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone), (503) 494-4997 (Fax)
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone), (503) 494-3092 (Fax)
Certifications:
Anesthesiology, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
3181 SW Sam Jackson Park Rd, Portland 97239
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
Education:
Medical School
Univ Of Ms Sch Of Med
Graduated: 1970
Naval Hospital
Graduated: 1971
Naval Med Center
Graduated: 1974
University Calif Hospital
Univ Of Ms Sch Of Med
Graduated: 1970
Naval Hospital
Graduated: 1971
Naval Med Center
Graduated: 1974
University Calif Hospital
James Stowers Hicks, Portland OR
Specialties:
Anesthesiologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology
James Hicks, Portland OR - Teacher
Specialties:
Fine Arts
Work:
Portland Community College - Portland OR
Methods Of Treatment And Diagnosis Of Kaposi's Sarcoma (Ks) And Ks Related Diseases
US Patent:
2006027, Dec 7, 2006
Filed:
Jan 6, 2004
Appl. No.:
10/541598
Inventors:
Ashlee Moses - Portland OR, US
Klaus Fruh - Portland OR, US
Jeffrey King - Portland OR, US
James Hicks - Portland OR, US
Camilo Raggo - Portland OR, US
Jay Nelson - Portland OR, US
Klaus Fruh - Portland OR, US
Jeffrey King - Portland OR, US
James Hicks - Portland OR, US
Camilo Raggo - Portland OR, US
Jay Nelson - Portland OR, US
Assignee:
Oregon Health & Science University - Portland OR
International Classification:
C12Q 1/70, C12Q 1/68
US Classification:
435006000, 435005000
Abstract:
The present invention uses gene expression profiling, and gene silencing methods to identify and provide a plurality of ‘validated’ KSHV-induced cellular gene sequences and pathways useful as targets for modulation of KSHV-mediated effects on cellular proliferation and phenotype (e.g., cancer) associated with latent and lytic phases of the Kaposi's sarcoma-associated herpesvirus (KSHV; Human herpesvirus 8; HHV8) life cycle. Particular embodiments provide therapeutic compositions, and methods for modulation of KSHV infection or KSHV-mediated effects on cellular proliferation and phenotype, comprising inhibition of KSHV-induced gene sequences. Additional embodiments provide screening assays for compounds useful to modulate KSHV infection or KSHV-mediated effects on cellular proliferation and phenotype. Further embodiments provide diagnostic and/or prognostic assays for KSHV infection.
Methods Of Treatment And Diagnosis Of Kaposi's Sarcoma (Ks) And Ks Related Diseases
US Patent:
2007007, Mar 29, 2007
Filed:
Jun 15, 2006
Appl. No.:
11/455281
Inventors:
Ashlee Moses - Portland OR, US
Klaus Frueh - Portland OR, US
Jeffrey King - Portland OR, US
James Hicks - Portland OR, US
Camilo Raggo - Portland OR, US
Jay Nelson - Tualatin OR, US
Klaus Frueh - Portland OR, US
Jeffrey King - Portland OR, US
James Hicks - Portland OR, US
Camilo Raggo - Portland OR, US
Jay Nelson - Tualatin OR, US
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435006000, 435007100
Abstract:
Aspects of the present invention use gene expression profiling, and gene silencing methods to identify and provide a plurality of ‘validated’ KSHV-induced cellular gene sequences and pathways useful as targets for modulation of KSHV-mediated effects on cellular proliferation and phenotype (e.g., cancer) associated with latent and lytic phases of the Kaposi's sarcoma-associated herpesvirus (KSHV; Human herpesvirus 8; HHV8) life cycle. Particular embodiments provide therapeutic compositions, and methods for modulation and treatment of KSHV infection or KSHV-mediated effects on cellular proliferation and phenotype, comprising inhibition of KSHV-induced gene sequences or products thereof. Additional embodiments provide screening assays for compounds useful to modulate KSHV infection or KSHV-mediated effects on cellular proliferation and phenotype. Further embodiments provide diagnostic and/or prognostic assays for KSHV infection or related conditions. Additional embodiments provide novel in vivo models for KSHV infection or related conditions. Yet further aspects provide novel methods for transforming a mammalian cell, comprising expressing, by recombinant means, a transforming amount of RDCI, Neuritin, or both, and further provide cells transformed thereby.